It was also revealed that more than 4,000 athletes were not drugs tested in 2016 before competing at the Games.

This came after Brazil was criticized by WADA during the Olympics in August for halting its drug testing program in the build-up to the Games.

The country’s Sports Ministry confirmed no anti-doping tests were carried out between July 1 and July 24, a move described by WADA as “unacceptable.”

Brazil claimed the decision was made after WADA suspended its testing laboratory in Rio de Janeiro in June.

The suspension was subsequently lifted, which led to WADA questioning why the second largest team at the Olympics was not being properly monitored at such a “crucial time.”

Brazil were briefly placed on a watch-list by WADA’s Foundation Board last November, but the establishment of a unique Brazilian anti-doping tribunal and the implementation of the Code within their legal system saw them avoid being declared non-compliant in March.

WADA threatened Azerbaijan with non-compliance in July.

Concerns were addressed in a meeting that same month and some assurances were given, WADA said afterwards, but a “whole range of recommendations from previous reports” had still not been acted upon.

Azeri officials claimed they did not have the funds to carry out testing because their budget had been taken up by hosting the inaugural European Games in Baku last year.

By Liam Morgan